Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$283K Buy
2,753
+145
+6% +$16.4K 0.17% 119
2025
Q4
$327K Sell
2,608
-8,503
-77% -$1.08M 0.21% 123
2025
Q3
$1.49M Buy
11,111
+296
+3% +$38.9K 1.04% 28
2025
Q2
$1.47M Buy
+10,815
New +$1.43M 1.34% 21
2025
Q1
Sell
-342
Closed -$38.7K 133
2024
Q4
$38.7K Sell
342
-61
-15% -$7.05K 0.03% 262
2024
Q3
$46.7K Sell
403
-15,188
-97% -$1.67M 0.03% 250
2024
Q2
$1.62M Buy
15,591
+2,097
+16% +$222K 1.17% 16
2024
Q1
$1.53M Buy
13,494
+1,336
+11% +$153K 1.15% 19
2023
Q4
$1.34M Buy
+12,158
New +$1.21M 1.09% 20

Other funds holding ABT

Caitlin John's ABT Position: Q1 2026 in Review

Caitlin John increased its Abbott (ABT) stake by 5.6% in Q1 2026, buying an estimated $16.4K and bringing the position to 2,753 shares worth $283K. The position accounts for 0.17% of the portfolio, ranked #119.

Caitlin John first reported a position in ABT in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.62M in Q2 2024. 3,084 funds tracked by Wall St. Rank hold ABT as of Q1 2026.

  • Caitlin John held 2,753 shares of Abbott worth $283K as of Q1 2026.
  • Caitlin John bought 145 Abbott shares in Q1 2026, an estimated $16.4K.
  • Abbott made up 0.17% of Caitlin John's portfolio in Q1 2026, its #119 holding.
  • Caitlin John first reported a position in Abbott in Q4 2023 and has held it in 9 quarters since.
  • Caitlin John's Abbott position peaked at $1.62M in Q2 2024.
  • 3,084 funds tracked by Wall St. Rank held Abbott as of Q1 2026.

Based on Caitlin John's 13F filing for Q1 2026, filed 13 May 2026.